Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
98.00    0.00 (0.00%)
Bid:
96.00
Ask:
100.00
Spread: 4.00 (4.167%)
Market Cap: £58.34m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Directorate Change

8 May 2017 07:35

Crystal Amber Fund Limited - Directorate Change

Crystal Amber Fund Limited - Directorate Change

PR Newswire

London, May 8

8 May 2017

Crystal Amber Fund Limited

(the “Company”)

Directorate Change

The Board of Crystal Amber Fund Limited is pleased to announce the appointment of Jane Le Maitre as a Non-executive Director of the Company with immediate effect.

Jane Le Maitre is a Fellow of the Institute of Chartered Accountants in England & Wales, a Chartered Tax Adviser and a member of the Institute of Directors. She started her career with Coopers & Lybrand in the UK and has been resident in Guernsey for more than 25 years. She joined KPMG (Channel Islands) in 1989 and became a Partner in 1995 where she remained until 2000 before becoming a director in the fiduciary division at Kleinwort Benson. After 5 years with Kleinwort Benson, she joined the Intertrust Group in Guernsey. She became Managing Director of Intertrust Reads Private Clients Limited in January 2007 before stepping down in 2013 to concentrate on client matters and continues to hold a number of executive positions in property and investment related entities.

Commenting on the appointment of Jane Le Maitre as a Non-executive Director, William Collins (Non-executive Chairman) said:

My fellow directors and I are very pleased to welcome Jane as a member of the Board and we look forward to working with her.”

For further enquiries please contact: Crystal Amber Fund Limited William Collins (Chairman) Tel: 01481 716 000 www.crystalamber.com Allenby Capital Limited - Nominated Adviser David Worlidge/James Thomas/Liz Kirchner Tel: 020 3328 5656 Winterflood Investment Trusts - Broker Joe Winkley/Neil Langford Tel: 020 3100 0160 Crystal Amber Advisers (UK) LLP – Investment Adviser Richard Bernstein Tel: 020 7478 9080

Appendix

Jane Anne Le Maitre (née Baker), aged 57, is, or has been within the last five years, a director or partner in the following companies and partnerships:

Current directorships and partnershipsPast directorships and partnerships held within the last five years
Allesley Investments Limited Boveton Estates Limited Cosford Investments Limited Island Properties Limited Joiedevie Limited La Ronde Investment Company Limited BGL Reads Trust Company Limited* BGL Trustees Limited* C.M.S. Limited* Channel Corporate Services Limited* Cosign Limited* Cosign Nominees Limited* Cosign Services Limited* First Tower Trustees Limited* FRIM Services Limited* Intertrust Fiduciary Company Limited* Intertrust International Management Limited* Intertrust Reads Private Clients Limited* Intertrust Trustee 2 (Guernsey) Limited* Intertrust Trustees (Guernsey) Limited* Intertrust Trustees Limited* MPR Trust Company Limited* Pritchards Trustees Limited* Spread Nominees Limited* Spread Services Limited* Spread Trustee Company Limited*Athos Group Limited* BDO Tax Limited* Boar Nominees Limited* Callisto Holdings Limited (Alternate Director) Caversham Insurance Limited EnTrustPermal Absolute Return Fund PCC Limited EnTrustPermal Absolute Return Master Fund Limited EnTrustPermal Special Situations Fund PCC Limited Holme Head Limited* Intertrust Fund Services (Guernsey) Limited* Intertrust Management Limited* Intertrust Secretaries (Guernsey) Limited* Intertrust Services Limited* Porthos Group Limited* Stocksfield Limited*

*Directorships connected to Mrs Le Maitre’s employment with Intertrust Group.

All of Mrs Le Maitre’s current directorships and partnerships relate to unlisted entities.

There are no other disclosures in accordance with Schedule 2(g) of the AIM Rules.

Date   Source Headline
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20255:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20254:15 pmRNSMonthly Net Asset Value
16th Dec 20255:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20256:18 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20255:43 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
9th Dec 20255:42 pmRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20255:36 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Dec 202510:17 amRNSShare Buyback Programme
2nd Dec 20251:08 pmRNSResult of AGM
1st Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Nov 20256:07 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20256:30 pmRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20257:00 amRNSShare Buyback Programme
20th Nov 20257:00 amRNSMonthly Net Asset Value
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 20256:05 pmRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20255:59 pmRNSHolding(s) in Company
14th Nov 20256:11 pmRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20257:05 amRNSProposed change of strategy and investment manager
13th Nov 20255:39 pmRNSTransaction in Own Shares and Total Voting Rights
6th Nov 20257:00 amRNSNotice of AGM
31st Oct 20255:30 pmRNSTotal Voting Rights
27th Oct 20256:13 pmRNSTransaction in Own Shares and Total Voting Rights
24th Oct 20259:51 amRNSMonthly Net Asset Value
24th Oct 20259:50 amRNSMonthly Net Asset Value
24th Oct 20259:48 amRNSMonthly Net Asset Value
24th Oct 20259:47 amRNSMonthly Net Asset Value
20th Oct 20256:29 pmRNSTransaction in Own Shares and Total Voting Rights
20th Oct 202511:11 amRNSShare Buyback Programme
17th Oct 20257:00 amRNSFinal Results
16th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
7th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
30th Sep 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20255:26 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Sep 20257:00 amRNS-RMorphic Medical Inc. appoints new CFO
10th Sep 20255:21 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20255:29 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20255:31 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.